Mesalamine Tablet, Delayed Release
Product Images NDC 72603-304

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 72603-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120scontainer (120scontainer)

Each delayed-release tablet of mesalamine contains 1.2 g of the active ingredient. It is recommended to store at 20°C to 25°C (68°F to 77°F) in a tight, light-resistant container. This medication is designed for once-daily use. For specific dosage information, refer to the package insert. Manufactured for Northstar Rx LLC, with manufacturing taking place at Annora Pharma Pvt. Ltd. in Telangana, India. Be sure to keep this and all medications out of the reach of children.*

FDA Label Image

Mesalaminedrtabsstructure (Mesalaminedrtabsstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.